Possible acute and chronic synergistic effect of dual chamber pacing and disopyramide in obstructive hypertrophic cardiomyopathy: a case report

Eur J Heart Fail. 2010 Jan;12(1):94-7. doi: 10.1093/eurjhf/hfp166. Epub 2009 Nov 25.

Abstract

It remains unclear whether the combination of dual-chamber (DDD) pacing and disopyramide can achieve prolonged left ventricular outflow tract (LVOT) gradient reduction and symptom relief in patients with obstructive hypertrophic cardiomyopathy (HCM). In an HCM patient with a severe LVOT gradient, the combination of DDD pacing and disopyramide achieved marked improvement of gradient in the catheter laboratory and also after medium-term follow-up. The patient's severe dyspnoea was alleviated during the follow-up period. This combination might enable physicians to treat and manage elderly symptomatic obstructive HCM patients with a severe LVOT gradient more effectively and less invasively.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anti-Arrhythmia Agents / therapeutic use*
  • Cardiac Pacing, Artificial / methods*
  • Cardiomyopathy, Hypertrophic / complications
  • Cardiomyopathy, Hypertrophic / therapy*
  • Combined Modality Therapy
  • Disopyramide / therapeutic use*
  • Female
  • Follow-Up Studies
  • Humans
  • Treatment Outcome
  • Ultrasonography
  • Ventricular Outflow Obstruction / diagnostic imaging
  • Ventricular Outflow Obstruction / etiology
  • Ventricular Outflow Obstruction / therapy*

Substances

  • Anti-Arrhythmia Agents
  • Disopyramide